Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Hepatitis

  Free Subscription


Articles published in Clin Infect Dis

Retrieve available abstracts of 107 articles:
HTML format



Single Articles


    July 2022
  1. HUDSON AG, Bonacci RA, Moorman AC, Penley M, et al
    Hepatitis C virus infection preceding an outbreak of HIV among persons who inject drugs- Kanawha County, West Virginia, 2019-2021.
    Clin Infect Dis. 2022 Jul 29. pii: 6651445. doi: 10.1093.
    PubMed     Abstract available


  2. HSU HY, Chen HL, Chiang CL, Lai MW, et al
    Characterization of Hepatitis B Virus in Tenofovir-Treated and Untreated Chronically Infected Mothers and Their Immunoprophylaxis Failure Infants.
    Clin Infect Dis. 2022 Jul 5. pii: 6629403. doi: 10.1093.
    PubMed     Abstract available


  3. MARATHE G, Moodie EE, Brouillette MJ, Delaunay CL, et al
    Impact of HCV cure on depressive symptoms in the HIV-HCV co-infected population in Canada.
    Clin Infect Dis. 2022 Jul 5. pii: 6629407. doi: 10.1093.
    PubMed     Abstract available


    May 2022
  4. MAK LY, Cheung KS, Hui RW, Wong DK, et al
    Enhanced liver fibrosis score stratifies hepatocellular carcinoma risk in patients with hepatitis B surface antigen seroclearance.
    Clin Infect Dis. 2022 May 20. pii: 6589789. doi: 10.1093.
    PubMed     Abstract available


  5. CHOW N, Wong D, Lai CL, Mak LY, et al
    Effect of antiviral treatment on hepatitis B virus integration and hepatocyte clonal expansion.
    Clin Infect Dis. 2022 May 20. pii: 6589784. doi: 10.1093.
    PubMed     Abstract available


  6. WONG RJ, Kaufman HW, Niles JK, Kapoor H, et al
    Simplifying Treatment Criteria in Chronic Hepatitis B: Reducing Barriers to Elimination.
    Clin Infect Dis. 2022 May 20. pii: 6589786. doi: 10.1093.
    PubMed     Abstract available


    April 2022
  7. JHAVERI R
    Elimination Means Everyone: Targeting Hepatitis C in Infants and Pregnant Patients.
    Clin Infect Dis. 2022 Apr 27. pii: 6574818. doi: 10.1093.
    PubMed    


  8. JOHANNESSON JM, Fridriksdottir RH, Love TJ, Runarsdottir V, et al
    HIGH RATE OF HCV REINFECTION AMONG RECENTLY INJECTING DRUG USERS: RESULTS FROM THE TRAP HEP C PROGRAM - A PROSPECTIVE NATIONWIDE, POPULATION-BASED STUDY.
    Clin Infect Dis. 2022 Apr 19. pii: 6570478. doi: 10.1093.
    PubMed     Abstract available


  9. GROVES J, Dodd RY, Foster GA, Stramer SL, et al
    Genotype Distribution and Demographic Characteristics of Hepatitis C Virus NAT Yield Cases among US Blood Donors.
    Clin Infect Dis. 2022 Apr 11. pii: 6566326. doi: 10.1093.
    PubMed     Abstract available


  10. KUSEJKO K, Salazar-Vizcaya L, Shah C, Stockle M, et al
    Sustained effect on hepatitis C elimination among men who have sex with men in the Swiss HIV Cohort Study: A systematic re-screening for hepatitis C RNA two years following a nation-wide elimination program.
    Clin Infect Dis. 2022 Apr 11. pii: 6566325. doi: 10.1093.
    PubMed     Abstract available


  11. ADES AE, Gordon F, Scott K, Collins IJ, et al
    Overall vertical transmission of HCV, transmission net of clearance, and timing of transmission.
    Clin Infect Dis. 2022 Apr 11. pii: 6566315. doi: 10.1093.
    PubMed     Abstract available


  12. ADES AE, Gordon F, Scott K, Collins IJ, et al
    Spontaneous Clearance Of Vertically Acquired Hepatitis C Infection: Implications For Testing And Treatment.
    Clin Infect Dis. 2022 Apr 9. pii: 6565752. doi: 10.1093.
    PubMed     Abstract available


  13. CARSON JM, Dore GJ, Lloyd AR, Grebely J, et al
    Hepatitis C virus reinfection following direct acting antiviral treatment in the prison setting: the SToP-C study.
    Clin Infect Dis. 2022 Apr 1. pii: 6562011. doi: 10.1093.
    PubMed     Abstract available


    March 2022
  14. AMIN J, Vaccher S, Templeton DJ, Bavinton B B, et al
    Low prior exposure and incidence of hepatitis C in HIV negative gay and bisexual men taking PrEP: findings from the EPIC-NSW prospective implementation study.
    Clin Infect Dis. 2022 Mar 30. pii: 6555792. doi: 10.1093.
    PubMed     Abstract available


  15. LEE TH, Hunt CM, Maier MM, Lowy E, et al
    Hepatitis B Virus-Related Care Quality In Patients With Hepatitis B/Hiv Coinfection Versus Hepatitis B Monoinfection: A National Cohort Study.
    Clin Infect Dis. 2022 Mar 29. pii: 6555659. doi: 10.1093.
    PubMed     Abstract available


  16. MOUTCHIA J, Njouom R, Rumpler E, Besombes C, et al
    Maternal Age at First Childbirth and Geographical Variation in Hepatitis B Virus Prevalence in Cameroon: Important Role of Mother-to-Child Transmission.
    Clin Infect Dis. 2022;74:836-845.
    PubMed     Abstract available


  17. HOENIGL M, Abramovitz D, Flores Ortega RE, Martin NK, et al
    Sustained impact of the COVID-2019 pandemic on HCV treatment initiations in the United States.
    Clin Infect Dis. 2022 Mar 2. pii: 6540915. doi: 10.1093.
    PubMed     Abstract available


    February 2022
  18. TRICKEY A, Croxford S, Emanuel E, Ijaz S, et al
    The effectiveness of low dead space syringes for reducing the risk of hepatitis C virus acquisition among people who inject drugs - findings from a national survey in England, Wales, and Northern Ireland.
    Clin Infect Dis. 2022 Feb 20. pii: 6532589. doi: 10.1093.
    PubMed     Abstract available


  19. TESHALE EH, Roberts H, Gupta N, Jiles R, et al
    Characteristics of persons treated for hepatitis C using national pharmacy claims data, United States, 2014-2020.
    Clin Infect Dis. 2022 Feb 16. pii: 6529537. doi: 10.1093.
    PubMed     Abstract available


  20. GORDON SC, Teshale EH, Spradling PR, Moorman AC, et al
    Lower rates of emergency visits and hospitalizations among chronic hepatitis C patients with sustained virological response to interferon-free direct-acting antiviral therapy (2014-2018).
    Clin Infect Dis. 2022 Feb 11. pii: 6526938. doi: 10.1093.
    PubMed     Abstract available


    December 2021
  21. HUANG YC, Sun HY, Sheng WH, Hsieh SM, et al
    Evolution of hepatitis B virus (HBV) serologic markers among antiretroviral-naive, young people living with HIV who had undergone neonatal HBV vaccination and initiated antiretroviral therapy.
    Clin Infect Dis. 2021 Dec 10. pii: 6459150. doi: 10.1093/cid/ciab1020.
    PubMed     Abstract available


  22. LIU CJ, Sheen IS, Chen CY, Chuang WL, et al
    Ledipasvir/Sofosbuvir for Patients Coinfected With Chronic Hepatitis C and Hepatitis B in Taiwan: Follow-up 108 Weeks Posttreatment.
    Clin Infect Dis. 2021 Dec 2. pii: 6448442. doi: 10.1093.
    PubMed     Abstract available


    November 2021
  23. LIU S, Deng R, Zhou B, Sun J, et al
    Is the World Health Organization Hepatitis B Virus (HBV) DNA Standard Appropriate for Standardizing Serum HBV RNA Assays?
    Clin Infect Dis. 2021;73:e2821-e2823.
    PubMed    


  24. WORETA TA, Chalasani N
    Fatty Liver Disease in Human Immunodeficiency Virus-Hepatitis B Virus Coinfection: A Cause for Concern.
    Clin Infect Dis. 2021;73:e3286-e3287.
    PubMed    


  25. LEE JH, Lee YB, Cho EJ, Yu SJ, et al
    Entecavir Plus Pegylated Interferon and Sequential Hepatitis B Virus Vaccination Increases Hepatitis B Surface Antigen Seroclearance: A Randomized Controlled Proof-of-Concept Study.
    Clin Infect Dis. 2021;73:e3308-e3316.
    PubMed     Abstract available


    October 2021
  26. SRIDHAR S, Yip CC, Lo KH, Wu S, et al
    Hepatitis E virus species C infection in humans, Hong Kong.
    Clin Infect Dis. 2021 Oct 27. pii: 6412704. doi: 10.1093.
    PubMed     Abstract available


  27. WELD ED, Astemborski J, Kirk GD, Sulkowski MS, et al
    Preferences of Persons with or at Risk for Hepatitis C for Long-Acting Treatments.
    Clin Infect Dis. 2021 Oct 26. pii: 6410743. doi: 10.1093.
    PubMed     Abstract available


  28. KHALILI M, King WC, Kleiner DE, Chung RT, et al
    Evolution of Fatty Liver Disease and Relationship With Lipoproteins and Clinical Outcomes in Hepatitis B/Human Immunodeficiency Virus Coinfection.
    Clin Infect Dis. 2021 Oct 25. pii: 6410628. doi: 10.1093.
    PubMed     Abstract available


  29. HARNEY BL, Sacks-Davis R, van Santen DK, Traeger M, et al
    The Incidence of Hepatitis C Among Gay, Bisexual, and Other Men Who Have Sex With Men in Australia, 2009-2019.
    Clin Infect Dis. 2021 Oct 25. pii: 6410633. doi: 10.1093.
    PubMed     Abstract available


    September 2021
  30. BAROCAS JA, Savinkina A, Lodi S, Epstein RL, et al
    Projected long-term impact of the COVID-19 pandemic on hepatitis C outcomes in the United States: a modelling study.
    Clin Infect Dis. 2021 Sep 9. pii: 6367757. doi: 10.1093.
    PubMed     Abstract available


  31. GAO Y, Kong F, Song X, Shang J, et al
    Pradefovir Treatment in Patients with Chronic Hepatitis B: Week 24 Results from a Multicenter, Double-blind, Randomized, Noninferiority, Phase 2 Trial.
    Clin Infect Dis. 2021 Sep 6. pii: 6364928. doi: 10.1093.
    PubMed     Abstract available


    August 2021
  32. TULLY DC, Hahn JA, Bean DJ, Evans JL, et al
    Identification of Genetically Related HCV Infections Among Self-Described Injecting Partnerships.
    Clin Infect Dis. 2021 Aug 27. pii: 6358610. doi: 10.1093.
    PubMed     Abstract available


  33. LIU L, Wang L, Zhang H, Ou W, et al
    Changing Epidemiology of Hepatitis B Virus and Hepatitis C Virus Coinfection in a Human Immunodeficiency Virus-Positive Population in China: Results From the Third and Fourth Nationwide Molecular Epidemiologic Surveys.
    Clin Infect Dis. 2021;73:642-649.
    PubMed     Abstract available


    July 2021
  34. GORMLEY MA, Akiyama MJ, Rennert L, Howard KA, et al
    Changes in health-related quality of life for HCV-infected people who inject drugs on opioid agonist treatment following sustained virologic response.
    Clin Infect Dis. 2021 Jul 31. pii: 6332893. doi: 10.1093.
    PubMed     Abstract available


  35. IJAZ S, Derrick J, Shute J, Ireland G, et al
    Mother To Infant Transmission Of Hepatitis B Virus In The Face Of Neonatal Immunisation Is Not Necessarily Primary Vaccine Failure.
    Clin Infect Dis. 2021 Jul 12. pii: 6319332. doi: 10.1093.
    PubMed     Abstract available


  36. DEZANET LNC, Kassime R, Miailhes P, Lascoux-Combe C, et al
    Effect of viral replication and liver fibrosis on all-cause mortality in HIV/HBV coinfected individuals: a retrospective analysis of a 15-year longitudinal cohort.
    Clin Infect Dis. 2021 Jul 1. pii: 6312684. doi: 10.1093.
    PubMed     Abstract available


    June 2021
  37. BARTLETT SR, Wong S, Yu A, Pearce M, et al
    The impact of current opioid agonist therapy on hepatitis C virus treatment initiation among people who use drugs from in the DAA era: A population-based study.
    Clin Infect Dis. 2021 Jun 14. pii: 6298569. doi: 10.1093.
    PubMed     Abstract available


  38. VALERIO H, Alavi M, Law M, McManus H, et al
    Opportunities to enhance linkage to hepatitis C care among hospitalised people with recent drug dependence in New South Wales, Australia: A population-based linkage study.
    Clin Infect Dis. 2021 Jun 9. pii: 6295650. doi: 10.1093.
    PubMed     Abstract available


  39. ONOFRIO FQ, Cooper C, Borgia SM, Vachon ML, et al
    Salvage Therapy with Sofosbuvir/Velpatasvir/Voxilaprevir in DAA-experienced Patients: Results from a Prospective Canadian Registry.
    Clin Infect Dis. 2021;72:e799-e805.
    PubMed     Abstract available


    May 2021
  40. BOEKE CE, Hiebert L, Waked I, Tsertsvadze T, et al
    Retreatment of Chronic Hepatitis C Infection: Real-World Regimens and Outcomes from National Treatment Programs in Three Low- and Middle-Income Countries.
    Clin Infect Dis. 2021 May 20. pii: 6279051. doi: 10.1093.
    PubMed     Abstract available


  41. TOY M, Hutton D, Harris AM, Nelson N, et al
    Cost-Effectiveness of One-Time Universal Screening for Chronic Hepatitis B Infection in Adults in the United States.
    Clin Infect Dis. 2021 May 6. pii: 6270943. doi: 10.1093.
    PubMed     Abstract available


    April 2021
  42. HEO M, Pericot-Valverde I, Rennert L, Akiyama MJ, et al
    Hepatitis C virus DAA treatment adherence patterns and SVR among people who inject drugs treated in opioid agonist therapy programs.
    Clin Infect Dis. 2021 Apr 20. pii: 6238636. doi: 10.1093.
    PubMed     Abstract available


  43. MERAT S, Sharifi AH, Poustchi H, Hajiani E, et al
    Erratum to: SD1000: High Sustained Viral Response Rate in 1361 Patients With Hepatitis C Genotypes 1, 2, 3, and 4 Using a Low-cost Fixed-dose Combination Tablet of Generic Sofosbuvir and Daclatasvir: A Multicenter Phase III Clinical Trial.
    Clin Infect Dis. 2021 Apr 15. pii: 6226813. doi: 10.1093/cid/ciaa1768.
    PubMed    


  44. LEE SK, Sung PS, Park SS, Min CK, et al
    Reactivation of resolved hepatitis B after daratumumab for multiple myeloma.
    Clin Infect Dis. 2021 Apr 13. pii: 6224403. doi: 10.1093.
    PubMed     Abstract available


    March 2021
  45. FACENTE SN, Patel S, Hecht J, Wilson E, et al
    Hepatitis C care cascades for three populations at high risk: low-income trans women, young people who inject drugs, and men who have sex with men and inject drugs.
    Clin Infect Dis. 2021 Mar 26. pii: 6188771. doi: 10.1093.
    PubMed     Abstract available


  46. CASSEB J, Marcusso RMN, Monteiro M, Assone T, et al
    Human T-Cell Lymphotropic Virus/Human Immunodeficiency Virus, and Hepatitis C Virus Coinfection: Clinical Outcomes After 22 Years of Follow-up in Sao Paulo City.
    Clin Infect Dis. 2021 Mar 2. pii: 6156779. doi: 10.1093/cid/ciaa1008.
    PubMed    


    February 2021
  47. SPRADLING PR, Zhong Y, Moorman AC, Rupp LB, et al
    The persistence of underreporting of hepatitis C as an underlying or contributing cause of death, 2011-2017.
    Clin Infect Dis. 2021 Feb 9. pii: 6131867. doi: 10.1093.
    PubMed     Abstract available


  48. TAMAKI N, Kurosaki M, Yasui Y, Mori N, et al
    Change in Fibrosis 4 Index as Predictor of High Risk of Incident Hepatocellular Carcinoma After Eradication of Hepatitis C Virus.
    Clin Infect Dis. 2021 Feb 5. pii: 6129141. doi: 10.1093/cid/ciaa1307.
    PubMed     Abstract available


    January 2021
  49. LIU L, Wang L, Zhang H, Ou W, et al
    Changing Epidemiology of HBV and HCV Co-Infection in HIV-Positive Population in China: Results from the Third and Fourth Nationwide Molecular Epidemiologic Surveys.
    Clin Infect Dis. 2021 Jan 27. pii: 6121253. doi: 10.1093.
    PubMed     Abstract available


  50. YAYA I, Dembele Keita B, Anoma C, Dah TTE, et al
    Low Seroprevalence of Hepatitis C Among Men Who Have Sex With Men in West Africa.
    Clin Infect Dis. 2021 Jan 25. pii: 6119726. doi: 10.1093.
    PubMed    


  51. SONG DS, Jang JW, Yoo SH, Kwon JH, et al
    Improving the prediction of relapse after nucleos(t)ide analogue discontinuation in patients with chronic hepatitis B.
    Clin Infect Dis. 2021 Jan 8. pii: 6071005. doi: 10.1093.
    PubMed     Abstract available


  52. COTTE L, Hocqueloux L, Lefebvre M, Pradat P, et al
    Microelimination or not? The changing epidemiology of HIV-HCV coinfection in France 2012-2018.
    Clin Infect Dis. 2021 Jan 5. pii: 6064641. doi: 10.1093/cid/ciaa1940.
    PubMed     Abstract available


  53. ZENG QL, Yu ZJ, Ji F, Li GM, et al
    Tenofovir Alafenamide to Prevent Perinatal Hepatitis B Transmission: A Multicenter, Prospective, Observational Study.
    Clin Infect Dis. 2021 Jan 4. pii: 6062485. doi: 10.1093/cid/ciaa1939.
    PubMed     Abstract available


    December 2020
  54. IRVIN R, Gamble T, Malone J, Wang Z, et al
    HPTN 078: High Prevalence of HCV Antibodies Among Urban U.S. Men Who Have Sex with Men (MSM) Independent of HIV Status.
    Clin Infect Dis. 2020 Dec 21. pii: 6042798. doi: 10.1093/cid/ciaa1869.
    PubMed     Abstract available


  55. HAI VV, Shimakawa Y, Kim J, Do Ngoc H, et al
    Assessment and simplification of treatment eligibility among patients with chronic hepatitis B infection in Vietnam.
    Clin Infect Dis. 2020 Dec 17. pii: 6040789. doi: 10.1093/cid/ciaa1814.
    PubMed     Abstract available


  56. KOOPSEN J, Parker E, Han AX, van de Laar T, et al
    HCV transmission among MSM in Amsterdam: external introductions may complicate micro-elimination efforts.
    Clin Infect Dis. 2020 Dec 8. pii: 6025521. doi: 10.1093/cid/ciaa1830.
    PubMed     Abstract available


  57. VINIKOOR MJ
    TREAT-B: simple low-cost diagnostic score for when to treat hepatitis B.
    Clin Infect Dis. 2020 Dec 4. pii: 6024449. doi: 10.1093/cid/ciaa1820.
    PubMed    


    November 2020
  58. CORMA-GOMEZ A, Macias J, Morano L, Rivero A, et al
    Liver stiffness-based strategies predict absence of variceal bleeding in cirrhotic HCV-infected patients with and without HIV-coinfection after sustained virological response.
    Clin Infect Dis. 2020 Nov 19. pii: 5992241. doi: 10.1093/cid/ciaa1726.
    PubMed     Abstract available


    October 2020
  59. ESAULENKO EV, Yakovlev AA, Volkov GA, Sukhoruk AA, et al
    Efficacy and Safety of a 3-Antigen (Pre-S1/Pre-S2/S) Hepatitis B Vaccine: Results of a Phase 3 randomized clinical trial in the Russian Federation.
    Clin Infect Dis. 2020 Oct 29. pii: 5942941. doi: 10.1093/cid/ciaa1649.
    PubMed     Abstract available


  60. DOYLE JS, van Santen DK, Iser D, Sasadeusz J, et al
    Micro-elimination of hepatitis C among people with HIV coinfection: declining incidence and prevalence accompanying a multi-center treatment scale-up trial.
    Clin Infect Dis. 2020 Oct 3. pii: 5917707. doi: 10.1093/cid/ciaa1500.
    PubMed     Abstract available


  61. LIU CH, Kao JH
    Last Mile to Microelimination of HCV Infection among People Living with HIV.
    Clin Infect Dis. 2020 Oct 1. pii: 5917174. doi: 10.1093/cid/ciaa1499.
    PubMed    


    September 2020
  62. PLUMB ID, Gounder PP, Nolen LD, Massay SC, et al
    Vaccination Status of Alaska Native Persons With Hepatitis A Virus Infection-Alaska, 1996-2018.
    Clin Infect Dis. 2020 Sep 24. pii: 5910738. doi: 10.1093/cid/ciaa1102.
    PubMed     Abstract available


  63. CARRERO A, Berenguer J, Hontanon V, Guardiola JM, et al
    Effects of HCV Eradication on Bone mineral density in HIV/HCV Coinfected Patients.
    Clin Infect Dis. 2020 Sep 15. pii: 5905898. doi: 10.1093/cid/ciaa1396.
    PubMed     Abstract available


  64. GINDIN Y, Gaggar A, Lok AS, Janssen HLA, et al
    DNA Methylation and Immune Cell Markers Demonstrate Evidence of Accelerated Aging in Patients with Chronic HBV or HCV, with or without HIV Co-Infection.
    Clin Infect Dis. 2020 Sep 11. pii: 5904184. doi: 10.1093/cid/ciaa1371.
    PubMed     Abstract available


  65. SULKOWSKI M, Wyles D
    Deja vu all over again: retreatment of HCV DAA failures- same satisfactory results, same unanswered questions.
    Clin Infect Dis. 2020 Sep 5. pii: 5901659. doi: 10.1093/cid/ciaa1329.
    PubMed    


  66. PAPALUCA T, Roberts SK, Strasser SI, Stuart KA, et al
    Efficacy and safety of sofosbuvir/velpatasvir/voxilaprevir for HCV NS5A-inhibitor experienced patients with difficult to cure characteristics.
    Clin Infect Dis. 2020 Sep 5. pii: 5901660. doi: 10.1093/cid/ciaa1318.
    PubMed     Abstract available


  67. KHALILI M, King WC, Kleiner DE, Jain MK, et al
    Fatty Liver Disease in a Prospective North American Cohort of Adults with HIV and Hepatitis B Coinfection.
    Clin Infect Dis. 2020 Sep 1. pii: 5900012. doi: 10.1093/cid/ciaa1303.
    PubMed     Abstract available


    August 2020
  68. PAN CQ
    The role of earlier use of immunoprophylaxis in preventing mother to child transmission of hepatitis B.
    Clin Infect Dis. 2020 Aug 20. pii: 5895015. doi: 10.1093/cid/ciaa1226.
    PubMed    


  69. CORMA-GOMEZ A, Macias J, Lacalle-Remigio JR, Tellez F, et al
    HIV infection is associated with lower risk of hepatocellular carcinoma after sustained virological response to direct-acting antivirals in hepatitis C infected-patients with advanced fibrosis.
    Clin Infect Dis. 2020 Aug 7. pii: 5885174. doi: 10.1093/cid/ciaa1111.
    PubMed     Abstract available


  70. BRAUN DL, Hampel B, Ledergerber B, Grube C, et al
    A treatment as prevention trial to eliminate hepatitis C among men who have sex with men living with HIV in the Swiss HIV Cohort Study.
    Clin Infect Dis. 2020 Aug 6. pii: 5881825. doi: 10.1093/cid/ciaa1124.
    PubMed     Abstract available


  71. ROCKSTROH JK
    Hepatitis C (HCV) microelimination in HIV-coinfected men who have sex with men (MSM): A low hanging fruit?
    Clin Infect Dis. 2020 Aug 5. pii: 5881444. doi: 10.1093/cid/ciaa1113.
    PubMed    


  72. GIBNEY KB, MacLachlan J, Coutts R, Higgins N, et al
    Incidence of invasive pneumococcal disease higher among people notified with markers of hepatitis C virus infection: Population-based surveillance in Victoria, Australia 2001-2017.
    Clin Infect Dis. 2020 Aug 4. pii: 5880584. doi: 10.1093/cid/ciaa1110.
    PubMed     Abstract available


    July 2020
  73. ANDERSON M, Gersch J, Luk KC, Dawson G, et al
    Circulating Pregenomic HBV RNA is Primarily Full-length in Chronic Hepatitis B Patients Undergoing Nucleos(t)ide Analogue Therapy.
    Clin Infect Dis. 2020 Jul 20. pii: 5873731. doi: 10.1093/cid/ciaa1015.
    PubMed     Abstract available


  74. TAN BK, Chalouni M, Ceron DS, Cinaud A, et al
    Atherosclerotic Cardiovascular Events in Patients Infected With Human Immunodeficiency Virus and Hepatitis C Virus.
    Clin Infect Dis. 2020 Jul 20. pii: 5873715. doi: 10.1093/cid/ciaa1014.
    PubMed     Abstract available


  75. GIANNINI EG, Bodini G, Marabotto E, Furnari M, et al
    Applicability of Parameters for the Non-Invasive Diagnosis of Esophageal Varices Needing Treatment to Cured HCV Patients.
    Clin Infect Dis. 2020 Jul 13. pii: 5870725. doi: 10.1093.
    PubMed    


  76. ZHANG H, Wang F, Zhu X, Chen Y, et al
    Antiviral Activity and Pharmacokinetics of the HBV Capsid Assembly Modulator GLS4 in Patients with Chronic HBV Infection.
    Clin Infect Dis. 2020 Jul 10. pii: 5869864. doi: 10.1093.
    PubMed     Abstract available


  77. FELD JJ, Matthews GV
    Don't wait: The benefits of early diagnosis in perinatal HCV transmission.
    Clin Infect Dis. 2020 Jul 8. pii: 5868960. doi: 10.1093.
    PubMed    


  78. GOWDA C, Smith S, Crim L, Moyer K, et al
    Nucleic Acid Testing for Diagnosis of Perinatally-Acquired Hepatitis C Virus Infection in Early Infancy.
    Clin Infect Dis. 2020 Jul 8. pii: 5868931. doi: 10.1093.
    PubMed     Abstract available


  79. HUANG H, Xu C, Liu L, Chen L, et al
    Increased protection of earlier use of immunoprophylaxis in preventing perinatal transmission of hepatitis B virus.
    Clin Infect Dis. 2020 Jul 8. pii: 5868509. doi: 10.1093.
    PubMed     Abstract available


    June 2020
  80. HUNG IF, Yap DY, Yip TP, Zhang RR, et al
    A double-blind randomized phase 2 controlled trial of intradermal hepatitis B vaccination with a topical Toll-like receptor 7 agonist imiquimod, in patients on dialysis.
    Clin Infect Dis. 2020 Jun 18. pii: 5859563. doi: 10.1093.
    PubMed     Abstract available


  81. LAI JC, Wong VW, Wong GL
    Reply to Sun et al.
    Clin Infect Dis. 2020;70:2748-2749.
    PubMed    


  82. NSANZIMANA S, Penkunas MJ, Liu CY, Sebuhoro D, et al
    Effectiveness of Direct-Acting Antivirals for the treatment of chronic hepatitis C in Rwanda: A retrospective study.
    Clin Infect Dis. 2020 Jun 6. pii: 5854316. doi: 10.1093.
    PubMed     Abstract available


  83. ROCKSTROH JK
    Non-invasive markers for monitoring fibrosis regression after HCV-cure: what do they promise?
    Clin Infect Dis. 2020 Jun 5. pii: 5854050. doi: 10.1093.
    PubMed    


  84. ANUGWOM CM, Aby ES, Debes JD
    Inverse association between chronic hepatitis B infection and COVID-19: immune-exhaustion or coincidence?
    Clin Infect Dis. 2020 Jun 5. pii: 5851928. doi: 10.1093.
    PubMed    


  85. KRONFLI N, Young J, Wang S, Cox J, et al
    Liver fibrosis in HIV-Hepatitis C virus (HCV) co-infection before and after sustained virologic response: what is the best non-invasive marker for monitoring regression?
    Clin Infect Dis. 2020 Jun 5. pii: 5854053. doi: 10.1093.
    PubMed     Abstract available


  86. CHANCHAROENTHANA W, Leelahavanichkul A
    Kidney Transplantation from HBsAg+ Living Donors to HBsAg- Recipients: Benefits and Risks.
    Clin Infect Dis. 2020 Jun 3. pii: 5850914. doi: 10.1093.
    PubMed    


    May 2020
  87. NEWSUM AM, Matser A, Schinkel J, van der Valk M, et al
    Incidence of HCV reinfection among HIV-positive MSM and its association with sexual risk behavior: a longitudinal analysis.
    Clin Infect Dis. 2020 May 27. pii: 5847810. doi: 10.1093.
    PubMed     Abstract available


  88. ABDEL-HAMEED EA, Rouster SD, Kottilil S, Sherman KE, et al
    The enhanced liver fibrosis (ELF)-Index predicts hepatic fibrosis superior to FIB4 and APRI in HIV/HCV infected patients.
    Clin Infect Dis. 2020 May 27. pii: 5847812. doi: 10.1093.
    PubMed     Abstract available


  89. HELLARD M, Drummer H, Scott N
    Striving for hepatitis C elimination - the role of a vaccine.
    Clin Infect Dis. 2020 May 25. pii: 5843664. doi: 10.1093.
    PubMed    


  90. GREBELY J, Tran L, Degenhardt L, Dowell-Day A, et al
    Association between opioid agonist therapy and testing, treatment uptake, and treatment outcomes for hepatitis C infection among people who inject drugs: A systematic review and meta-analysis.
    Clin Infect Dis. 2020 May 24. pii: 5843586. doi: 10.1093.
    PubMed     Abstract available


  91. KATTAKUZHY S, Rosenthal E
    To Eliminate Hepatitis C in People Who Inject Drugs, Stop Ignoring Drug User Health.
    Clin Infect Dis. 2020 May 23. pii: 5843471. doi: 10.1093.
    PubMed    


  92. COX A, Sulkowski M, Sugarman J
    Ethical and Practical Issues Associated with the Possibility of Using Controlled Human Infection Trials in Developing a Hepatitis C Virus Vaccine.
    Clin Infect Dis. 2020 May 22. pii: 5842210. doi: 10.1093.
    PubMed     Abstract available


  93. VALERIO H, Alavi M, Silk D, Treloar C, et al
    Progress towards elimination of hepatitis C infection among people who inject drugs in Australia: The ETHOS Engage Study.
    Clin Infect Dis. 2020 May 18. pii: 5838577. doi: 10.1093.
    PubMed     Abstract available


  94. SETH A, Sherman KE
    Editorial: HCV Cure is the Start of the End For Those With Advanced Fibrosis/Cirrhosis.
    Clin Infect Dis. 2020 May 9. pii: 5835187. doi: 10.1093.
    PubMed    


  95. DIEZ C, Berenguer J, Ibanez-Samaniego L, Llop E, et al
    Persistence of clinically significant portal hypertension after eradication of HCV in patients with advanced cirrhosis.
    Clin Infect Dis. 2020 May 9. pii: 5835009. doi: 10.1093.
    PubMed     Abstract available


    April 2020
  96. CHAILLON A, Wynn A, Kushner T, Reau N, et al
    Cost-Effectiveness of Antenatal Rescreening Among Pregnant Women for Hepatitis C in the United States.
    Clin Infect Dis. 2020 Apr 13. pii: 5819607. doi: 10.1093.
    PubMed     Abstract available


  97. WONG CY, Zhu W, Aurigemma GP, Furukawa N, et al
    Infective endocarditis among persons aged 18-64 years with HIV, hepatitis C infection, or opioid use disorder - United States, 2007-2017.
    Clin Infect Dis. 2020 Apr 9. pii: 5818223. doi: 10.1093.
    PubMed     Abstract available


  98. ZHAO J, Liao X, Wang H, Wei L, et al
    Early virus clearance and delayed antibody response in a case of COVID-19 with a history of co-infection with HIV-1 and HCV.
    Clin Infect Dis. 2020 Apr 9. pii: 5818121. doi: 10.1093.
    PubMed     Abstract available


  99. DORE GJ, Cowie B
    Global Hepatitis B Virus Elimination by 2030: China Is Pivotal and Instructive.
    Clin Infect Dis. 2020 Apr 7. pii: 5817060. doi: 10.1093.
    PubMed    


  100. NAYAGAM S, Chan P, Zhao K, Sicuri E, et al
    Investment Case for a Comprehensive Package of Interventions Against Hepatitis B in China: Applied Modeling to Help National Strategy Planning.
    Clin Infect Dis. 2020 Apr 7. pii: 5817057. doi: 10.1093.
    PubMed     Abstract available


    February 2020
  101. WANG XD, Liu JP, Song TR, Huang ZL, et al
    Kidney Transplantation from HBsAg+ Living Donors to HBsAg- Recipients: Clinical Outcomes at a High-volume Center in China.
    Clin Infect Dis. 2020 Feb 26. pii: 5758069. doi: 10.1093.
    PubMed     Abstract available


    January 2020
  102. PATEL EU, Mehta SH, Boon D, Quinn TC, et al
    Reply to MacDonald et al.
    Clin Infect Dis. 2020;70:544-545.
    PubMed    


    December 2019
  103. BOGLIONE L, Lipani F, Lucchini AM, Salvador E, et al
    Antiviral therapy in patients with HBV treated for tuberculosis: a forgotten issue.
    Clin Infect Dis. 2019 Dec 17. pii: 5679635. doi: 10.1093/cid/ciz1199.
    PubMed    


    August 2019
  104. SEROTA DP, Barocas JA, Springer SA
    Infectious complications of addiction: A call for a new subspecialty within infectious diseases.
    Clin Infect Dis. 2019 Aug 17. pii: 5550920. doi: 10.1093.
    PubMed     Abstract available


    February 2019
  105. HEFELE L, Syphan S, Xayavong D, Homsana A, et al
    Seroprotection at different levels of the health care system after routine vaccination with DTPw-HepB-Hib in Lao PDR.
    Clin Infect Dis. 2019 Feb 19. pii: 5335760. doi: 10.1093.
    PubMed     Abstract available


    December 2018
  106. BENMASSAOUD A, Nitulescu R, Pembroke T, Halme AS, et al
    Liver-related events in HIV-infected persons with occult cirrhosis.
    Clin Infect Dis. 2018 Dec 18. pii: 5251034. doi: 10.1093/cid/ciy1082.
    PubMed     Abstract available


    September 2018
  107. SHERMAN KE, Abdel-Hameed E, Rouster SD, Shata MTM, et al
    Improvement in Hepatic Fibrosis Biomarkers Associated with Chemokine Receptor Inactivation through Mutation or Therapeutic Blockade.
    Clin Infect Dis. 2018 Sep 20. pii: 5104288. doi: 10.1093.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hepatitis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: